The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

10551–10575 of 17785

  • ModerateFDA (Drugs)·D-0880-2017·2017-06-07

    Saphris Asenapine Tablets Recalled for Labeling Mixup

    Forest Laboratories is recalling Saphris (asenapine) sublingual tablets because blister packs labeled as 10 mg actually contain 5 mg tablets.

    Product
    SAPHRIS — SAPHRIS (ASENAPINE MALEATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0869-2017·2017-06-07

    VistaPharm Recalls Nystatin Oral Suspension Due to Impurity

    VistaPharm is recalling Nystatin Oral Suspension because it contains an impurity peak that exceeds approved specifications.

    Product
    Nystatin Oral Suspension, USP, 100,000 units/mL, packaged in a) 2 fl.oz. (60mL) bottles (NDC 66689-008-02), and 500,000 units/5mL individual unit dose cup (NDC 66689-037-01) packaged in b) 50 count unit dose cups/case (NDC 66689-037-50) and c) 100 count unit dose cups/case (NDC 6
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0868-2017·2017-06-07

    Sandoz Recalls Subpotent Amoxicillin and Clavulanate Potassium Tablets

    Sandoz Inc is recalling 4,464 bottles of Amoxicillin and Clavulanate Potassium tablets found to be subpotent in clavulanic acid.

    Product
    AMOXICILLIN AND CLAVULANATE POTASSIUM — AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN AND CLAVULANATE POTASSIUM)
    Category
    Drug
    Distribution
    2 states
  • CriticalFDA (Drugs)·D-0862-2017·2017-05-31

    Hospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate

    Hospira is recalling 71,550 syringes of Infant 25% Dextrose Injection because human hair was found in an internal sample. The product was distributed nationwide and in Puerto Rico.

    Product
    DEXTROSE — DEXTROSE (DEXTROSE MONOHYDRATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-0863-2017·2017-05-31

    Hyland's Baby Teething Tablets Recalled for Inconsistent Belladonna Alkaloid Levels

    Standard Homeopathic Company is recalling Hyland's Baby Teething Tablets because FDA analysis found inconsistent amounts of belladonna alkaloids that may differ from label claims.

    Product
    Hyland's Baby Teething Tablets [Calcarea Phosporica 6X HPUS, Chamomilla 6X HPUS, Coffea Cruda 6X HPUS, Belladonna 12X HPUS (0.0000000000003% alkaloids, calculated)] Quick-Dissolving Tablets, packaged in a) 40-count bottles (NDC 54973-3127-3) (UPC 3 54973 31273 9); b) 135-count bo
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-0864-2017·2017-05-31

    Hyland's Baby Nighttime Teething Tablets Recalled for Inconsistent Belladonna Alkaloids

    Standard Homeopathic Company is recalling Hyland's Baby Nighttime Teething Tablets because FDA analysis found inconsistent amounts of belladonna alkaloids.

    Product
    Hyland's Baby Nighttime Teething Tablets [Belladonna 12X HPUS (0.0000000000003% alkaloids, calculated), Calcarea Phosphorica 6X HPUS, Chamomilla 6X HPUS, Coffea Cruda 6X HPUS, Magnesia Phosphorica 6X HPUS, Rheum 6X HPUS, Silicea 12X HPUS] Quick-Dissolving Tablets, 135-count bottl
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-0867-2017·2017-05-31

    Envy Me Recalls LaBri's Body Health Atomic Due to Undeclared Sibutramine

    Envy Me is recalling LaBri's Body Health Atomic capsules because the product contains undeclared Sibutramine and was marketed without an approved NDA/ANDA.

    Product
    LaBri's Body Health Atomic, 60 capsules
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0856-2017·2017-05-31

    Sato Pharmaceutical Recalls DORAMA-NEO Eye Wash Due to Sterility Concerns

    Sato Pharmaceutical Inc. is recalling 14,325 bottles of DORAMA-NEO eye wash because the manufacturer failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.

    Product
    DORAMA-NEO (naphazoline hydrochloride) Eye wash, packaged in 0.5 FL OZ (15mL) bottles, Manufactured by SATO Pharmaceuticals CO., LTD. 1-5-27 Motoakasaka Minato-Ku Tokyo, Japan, NDC 49873-020-01
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0855-2017·2017-05-31

    Sato Clear Eye Drops Recalled for Sterility Assurance Failure

    Sato Pharmaceutical is recalling Sato Clear eye drops because the firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.

    Product
    SATO CLEAR (naphazoline hydrochloride) Redness Reliever Eye Drops, packaged in 0.5 FL OZ (15mL) bottles, Manufactured by SATO Pharmaceuticals CO., LTD. 1-5-27 Motoakasaka Minato-Ku Tokyo, Japan, NDC 49873-044-01
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0854-2017·2017-05-31

    Sato Pharmaceutical Recalls Optic Splash Eye Drops Due to Sterility Concerns

    Sato Pharmaceutical Inc. is recalling 10,130 bottles of Optic Splash eye drops because the firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.

    Product
    Optic Splash (naphazoline hydrochloride) Eye Drops, packaged in 0.5 FL OZ (15mL) bottles, Manufactured by SATO Pharmaceuticals CO., LTD. 1-5-27 Motoakasaka Minato-Ku Tokyo, Japan, NDC 49873-501-01.
    Category
    Drug
    Distribution
    2 states
  • ModerateFDA (Drugs)·D-0839-2017·2017-05-31

    Advanced Pharma Recalls Neostigmine Methylsulfate Due to Latex Labeling Defect

    Advanced Pharma Inc. is recalling all strengths and dosage forms of Neostigmine Methylsulfate because the product may contain latex without proper labeling.

    Product
    Neostigmine Methylsulfate all strengths, all dosage forms and all packaging, Rx Only, Avella of Houston, Houston, TX 77054
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0829-2017·2017-05-31

    Advanced Pharma Recalls Calcium Gluconate for Latex Labeling Deficiency

    Advanced Pharma Inc. is recalling Calcium Gluconate products because they may contain latex without proper labeling.

    Product
    Calcium Gluconate all strengths, all dosage forms and all packaging, Rx Only, Avella of Houston, Houston, TX 77054
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0851-2017·2017-05-31

    Advanced Pharma Recalls Sodium Citrate Due to Latex Labeling Defect

    Advanced Pharma Inc. is recalling all strengths and dosage forms of Sodium Citrate because the product may contain latex without proper labeling.

    Product
    Sodium Citrate all strengths, all dosage forms and all packaging, Rx Only, Avella of Houston, Houston, TX 77054
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0706-2017·2017-05-31

    Mylan Recalls Alprazolam Extended-Release Tablets for Dissolution Failures

    Mylan Pharmaceuticals is recalling specific lots of Alprazolam Extended-Release Tablets because they failed to meet dissolution specifications.

    Product
    Alprazolam Extended-release Tablets, USP, 1 mg, 60-count bottle, Rx Only, Manufactured and Distributed by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5022-91
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0815-2017·2017-05-31

    Advanced Pharma Recalls Lorazepam HCl Due to Latex Labeling

    Advanced Pharma Inc. is recalling all lots of Lorazepam HCl because the product may contain synthetic or natural latex, which is not currently labeled.

    Product
    Lorazepam HCl all strengths, all dosage forms and all packaging, Rx Only, Avella of Houston, Houston, TX 77054
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0838-2017·2017-05-31

    Advanced Pharma Recalls Glycopyrrolate for Potential Latex Content

    Advanced Pharma Inc. is recalling all strengths and dosage forms of Glycopyrrolate because the product may contain synthetic or natural latex.

    Product
    Glycopyrrolate all strengths, all dosage forms and all packaging, Rx Only, Avella of Houston, Houston, TX 77054
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0794-2017·2017-05-31

    Advanced Pharma Recalls Bupivacaine HCl Due to Latex Labeling Defect

    Advanced Pharma Inc. is recalling Bupivacaine HCl in 0.9% Sodium Chloride because the product may contain synthetic or natural latex, which is not properly labeled.

    Product
    Bupivacaine HCl in 0.9% Sodium Chloride all strengths, all dosage forms and all packaging, Rx Only, Avella of Houston, Houston, TX 77054
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0827-2017·2017-05-31

    Advanced Pharma Recalls Norepinephrine Bitartrate for Latex Labeling

    Advanced Pharma Inc. is recalling all lots of Norepinephrine Bitartrate because the product may contain synthetic or natural latex, which is not currently disclosed on the label.

    Product
    Norepinephrine Bitartrate all strengths, all dosage forms and all packaging, Rx Only, Avella of Houston, Houston, TX 77054
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0819-2017·2017-05-31

    Advanced Pharma Recalls Penicillin G Potassium for Latex Labeling Defect

    Advanced Pharma Inc. is recalling all lots of Penicillin G Potassium because the product may contain latex but lacks appropriate labeling.

    Product
    Penicillin G Potassium all strengths, all dosage forms and all packaging, Rx Only, Avella of Houston, Houston, TX 77054
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0861-2017·2017-05-31

    Mylan Recalls Norethindrone Acetate and Ethinyl Estradiol Tablets Due to Contamination

    Mylan Pharmaceuticals is recalling specific lots of oral contraceptive tablets due to chemical contamination from paint thinner vapors during facility repairs.

    Product
    NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL — NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0828-2017·2017-05-31

    Advanced Pharma Recalls Epinephrine HCl Products Due to Latex Labeling

    Advanced Pharma Inc. is recalling all Epinephrine HCl products because they may contain latex but lack appropriate labeling.

    Product
    Epinephrine HCl all strengths, all dosage forms and all packaging, Rx Only, Avella of Houston, Houston, TX 77054
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0848-2017·2017-05-31

    Magnesium Sulfate Recall for Potential Latex Content

    Advanced Pharma Inc. is recalling Magnesium Sulfate products due to potential latex content not clearly labeled.

    Product
    Magnesium Sulfate all strengths, all dosage forms and all packaging, Rx Only, Avella of Houston, Houston, TX 77054
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0834-2017·2017-05-31

    Advanced Pharma Recalls Nicardipine HCl Due to Latex Labeling

    Advanced Pharma Inc. is recalling all lots of Nicardipine HCl because the product may contain latex but lacks appropriate labeling.

    Product
    Nicardipine HCl all strengths, all dosage forms and all packaging, Rx Only, Avella of Houston, Houston, TX 77054
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0853-2017·2017-05-31

    Advanced Pharma Recalls Fentanyl and Bupivacaine Products for Latex Labeling

    Advanced Pharma Inc. is recalling Fentanyl Citrate and Bupivacaine HCl products because labeling may not disclose the presence of synthetic or natural latex.

    Product
    Fentanyl Citrate and Bupivacaine HCl all strengths, all dosage forms and all packaging, Rx Only, Avella of Houston, Houston, TX 77054
    Category
    Drug
    Distribution
    Distributed nationwide